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EDITORIAL
Glomerulosclerosis and hypoplasia—A common theme?
Glomerulosclerosis is a common pathological finding genetic backgrounds [7]. While reduced nephron num-
ber, glomerular hypertrophy and cell turnover were iden-associated with the progressive decline in renal function
that follows a variety of acute and chronic renal insults. tical in C57 Os/1 and ROP Os/1 mice, severe mesangial
sclerosis was restricted to ROP Os/1 mice. In indepen-The complex pathophysiology of glomerulosclerosis is
triggered by changes in renal hemodynamics following dent studies, Gilbert et al demonstrated that glomerular
number was decreased in pups of female sclerosis-pronethe loss of functional nephrons [1]. It logically follows
that a decreased number of nephrons at birth might be (Sprague-Dawley) rats that had received gentamicin
from embryonic days 8–12 [8]. Most recently, in a pro-associated with an increased risk of glomerulosclerosis
in adult life [2, 3]. Indeed, children with oligomega- ductive collaborative effort reported in this issue of Kid-
ney International, these two laboratory groups joinednephronia, an uncommon disease characterized by as
much as an 80% reduction in nephron number at birth, forces to determine whether there was a relationship
between increased susceptibility to glomerulosclerosisgenerally experience early progression to end-stage renal
failure [4]. and increased fetal susceptibility to a commonly used
nephrotoxin, gentamicin [9]. Using a well-designed setIn addition to oligomeganephronia, a number of syn-
dromes associated with renal aplasia, hypoplasia, and of in vivo and in vitro experiments, they determined that
ureteric bud branching and glomerular formation weredysplasia lead to a congenital reduction in nephron mass
[5]. Epidemiologically, multiple factors have been associ- decreased in sclerosis-prone (ROP 1/1), but not sclero-
sis-resistant (C57 B1/6) mice following intrauterine gen-ated with decreased nephron formation, including low
placental weight, low birth weight, and exposure to tox- tamicin exposure. Although this study did not address
specific mechanisms, the data presented suggest thatins in utero. Nephrogenesis is a complex, coordinated
process of proliferation, cell death, morphogenetic pat- there is an association between susceptibility to glomer-
usclerosis in adulthood and reduction in nephron num-terning, and functional differentiation that is controlled
by a tightly regulated program of specific gene expression ber in utero. The authors conclude that “. . . exposure to
[6]. Any perturation of this well-orchestrated, develop- nephrotoxins in utero compounds the risk of renal failure
mental program can result in a reduced complement of as an adult in sclerosis-prone individuals” [9].
nephrons at birth. But what is the genotype of a sclerosis-prone individ-
Although intrauterine exposure to certain toxins has ual? What are the common genetic features of individu-
been experimentally associated with abnormalities of als risk of severe renal developmental abnormalities with
kidney development, and reduced nephron number at in utero nephrotoxin exposure and those who are predis-
birth has been associated with an increased susceptibility posed to glomerulosclerosis following a variety of insults?
to glomerulosclerosis, these relationships are not consis- The answers to these questions await clear delineation
tent. There is significant variability in any given individu- of the genetic basis for abnormal kidney development
al’s response to nephrotoxin exposure, and many individ- and glomerulosclerosis. New molecular technologies
uals with reduced renal mass at birth do not develop permit exciting and innovative approaches to such ques-
progressive renal dysfunction as adults. Recent studies tions. The development of high throughput, automated
suggest that there are specific genetic factors which in- applications of chip-based gene and protein expression
fluence both a predisposition to in utero renal injury and technology will permit the identification of specific ge-
glomerular scarring [7–9]. netic profiles of renal disease pathophysiology and sus-
He et al demonstrated that genetic susceptibility to ceptibility [10]. For now, one can only speculate about
glomerulosclerosis was independent of reduction in possible interactions of the pathways regulating nephron
nephron number by expressing the radiation-induced Os formation and glomerulosclerosis. Common pathophysi-
murine mutation (which results in oligosyndactyly and ological intermediates identified to date include mem-
a congenital reduction in nephron number) on different bers of the TGF-b superfamily and angiotensin II [1, 6].
The clinician can look forward to a brave new world
where nephron preservation therapies are individuallyKey words: nephrogenesis, nephrotoxin exposure, gentamicin, de-
creased nephron mass, progressive renal dysfunction. tailored for specific genetic susceptibility profiles. Until
then we must be content to minimize exposure to 1999 by the International Society of Nephrology
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